Related by context. All words. (Click for frequent words.) 73 candidate Hematide TM 72 Xcytrin R 71 Hematide TM 71 Hematide ™ peginesatide 71 pralatrexate injection folate analogue 70 compound INCB# 70 Telik logo TELINTRA 70 LibiGel ® testosterone gel 70 candidate REP# 69 CB2 selective receptor agonist 69 Second Pivotal Phase 69 XL# anticancer compounds 69 Inc. www.micromet inc.com 69 Completes Patient Enrollment 68 virus HCV protease inhibitor 68 IMPDH inhibitor 68 ThermoDox ® clinical 68 vosaroxin 68 Alvine Pharmaceuticals 68 PNP inhibitor 68 Crofelemer budesonide foam 68 FOLOTYN ® 68 Initiates Enrollment 68 OvaRex R 68 HEPLISAV ™ 68 PDX pralatrexate 67 HepeX B 67 apricitabine ATC 67 Initiates Phase III 67 Oracea TM 67 Naglazyme R 67 IMiDs R 67 non nucleoside HCV 67 telomerase therapeutic 67 targeted radiotherapeutic 67 Arno Therapeutics 67 Archexin 67 Personalized Immunotherapy 67 dimebon latrepirdine 67 Empatic ™ 67 pharmacogenomic translational research 67 AAG geldanamycin analog 67 Initiates Clinical 67 Initiates Phase II 67 candidate deforolimus 67 candidate AQ4N 67 OMAPRO ™ 67 recurrent metastatic ovarian cancer 67 Phase III Pivotal 67 Oral Calcitonin 67 oral prodrug 67 alvespimycin 67 Rigel R# 67 successfully commercialize Iluvien 66 anti botulism antibody 66 molecular imaging radiopharmaceutical 66 Successfully Completes Phase 66 Lisofylline LSF 66 Asentar TM 66 4SC AG ISIN DE# 66 peginesatide 66 R MSCRAMM 66 investigational hepatitis B 66 oral isotype selective HDAC 66 PLK1 SNALP 66 oncolytic virus therapies 66 motexafin gadolinium Injection 66 MAb therapy 66 Ostarine ™ 66 HuMax TAC 66 elotuzumab 66 JAK2 Inhibitor 66 MAA submission 66 PANVAC VF 66 XL# XL# XL# XL# 66 HepeX B TM 66 PEG SN# 66 ALS #-# 66 Panzem R 66 trastuzumab DM1 T DM1 66 SUCCEED trial 66 subsidiaries visit http:/www.apricusbio.com 66 defensin mimetic antibiotic 66 compound PMX # 66 sapacitabine CYC# 66 Entereg R 66 polysaccharide polymer 66 JAK inhibitor 66 Aganocide 66 MKC# MT 66 GATTEX ® 66 Maxy G# 66 Submits Biologics License Application 66 GATTEX TM 66 IMiDs ® 66 Submits Response 66 KRYSTEXXA TM pegloticase 66 FDA Accepts 66 MKC# MKC# PP 66 Genitope Corporation 66 investigational humanized monoclonal antibody 66 Receives Orphan Drug 66 markets HP Acthar 65 Acetavance TM 65 PDE4 inhibitor 65 Begins Dosing 65 midstage clinical 65 EVIZON TM squalamine lactate 65 recombinant PSMA vaccine 65 Miraxion Amarin lead 65 Fx #A 65 Aganocide R 65 Receives Milestone Payment 65 includes TOLAMBA TM 65 ALTROPANE R 65 pentadentate logo R 65 HEPLISAV TM 65 novel MetAP 2 65 Gentamicin Surgical Implant 65 Glufosfamide 65 #/#/# Cytokinetics Incorporated 65 DPX Survivac 65 SILENOR 65 TRO# 65 PROVENGE sipuleucel T 65 omecamtiv mecarbil formerly 65 Anturol TM 65 please visit http:/www.atherogenics.com 65 OvaRex ® MAb 65 Phase Ib clinical trials 65 SinuNase ™ 65 Ostabolin C TM 65 deforolimus 65 Pivotal Phase 65 Pegloticase 65 pan BCR ABL 65 Files Investigational 65 Meets Primary Endpoint 65 highly purified pasteurized 65 IL# PE#QQR 65 NDA Submission 65 TRACON Pharmaceuticals 65 Initiate Phase 65 MGCD# [001] 65 solid tumors ZYBRESTAT 65 Zenvia ™ 65 PF # [002] 65 RNAi Therapeutic 65 unique alkylating agent 65 Kosan dependence 65 Amigal TM 65 FavId 65 PRECISE Trial 65 Receives Orphan Drug Designation 65 ASONEP 65 SPL# Gel vaginal microbicide 65 sodium Injection 65 candidate ridaforolimus 65 Receives Fast Track 65 TBC# 65 #D#C# 65 JOULFERON 64 class mGluR5 inhibitor 64 molecular chaperone regulation 64 Phase 2a clinical trials 64 SinuNase TM 64 Trofex ™ 64 Phase 2b Clinical Trial 64 CRMD# 64 REMOXY POSIDUR ELADUR 64 Adnectin 64 Testosterone MDTS ® 64 dacetuzumab SGN 64 JZP 64 Silodosin 64 Ridaforolimus 64 ONCONASE R 64 hypoxia activated prodrug 64 TRIOLEX ™ 64 Budesonide foam crofelemer 64 IND submission 64 developing Zerenex TM 64 Angiocept 64 Earns Milestone Payment 64 TNFerade ™ 64 commercialize CorMedix drug 64 Genasense ® oblimersen 64 KAI Pharmaceuticals 64 oral dihydropyrimidine dehydrogenase DPD 64 topical antifungal product 64 ENABLE Phase 2 64 metaglidasen 64 HGS ETR2 64 non nucleoside inhibitor 64 hypoxia selective 64 symbol AVXL 64 leading oral taxane 64 Exelixis compounds 64 RIGScan CR 64 First Patient Enrolled 64 Allovectin 7 r 64 developing ostarine selective 64 novel therapeutic antibodies 64 Trastuzumab DM1 64 Commences Phase 64 oral proteasome inhibitor 64 ALN PCS 64 BRILINTA 64 ENRICH trial 64 atacicept 64 Inc Therapeutic Competitors 64 Presents Preclinical Data 64 R#/MEM # 64 GLP1 INT TM 64 huC# DM4 64 Initiates Clinical Trial 64 CEQ# 64 oral isoform selective HDAC 64 Spiegelmer ® 64 Cannabinor 64 TACI Ig 64 TRANSDUR ® 64 Unit Dose Budesonide 64 Receive Milestone Payment 64 GVAX R 64 Phase #b/#a clinical 64 torezolid phosphate 64 Aganocide ® 64 tramiprosate Alzhemed TM 64 ABL inhibitor completing 64 GSK# [002] 64 Bioral Amphotericin B 64 Presents Positive 64 RNAi Therapeutics 64 E CENP E 64 Idera Pharmaceuticals 64 Prodarsan R 64 Granted Orphan Drug 64 sulfonylhydrazine class 64 delivers fluocinolone acetonide FA 64 agonistic human 64 eritoran 64 ELND-#/AZD-# 64 candidate brentuximab vedotin 64 class anticancer quinolone 64 please visit www.medicinova.com 64 product platforms AZX# 64 BRIM2 64 novel antifolate currently 64 clinical trials dacetuzumab SGN 64 HGS ETR1 64 Pivotal Phase III 64 PHX# 64 rxRNA 64 Cardium Therapeutics TM 64 selectin antagonist 64 non porcine pancreatic 64 Curaxin CBLC# 64 Romiplostim 64 CD# CEA 64 GTC NASDAQ GTCB 64 Anturol ® 64 TELINTRA R 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 IMA# 64 Completes Dosing 64 GALNS 64 Fast Track designations 64 please visit http:/www.sunesis.com 64 Preclinical Development 63 TELINTRA 63 Ophthotech 63 DNA RNA Medicines 63 AcryMed technologies 63 lintuzumab SGN 63 certain protein tyrosine 63 phase IIb clinical 63 ARRY # 63 IG HCR ;) CO 63 Tezampanel 63 Albugon 63 IMC #B 63 TRANSDUR Bupivacaine 63 acetylgalactosamine 6 63 Zemiva TM 63 Through Glycoscience R 63 Nasdaq PGNX today 63 IgG1 monoclonal antibody 63 naronapride 63 CORLUX CORT # 63 mocetinostat MGCD# 63 Plicera 63 pradefovir 63 adrenergic regulation 63 website www.celsion.com 63 REG1 Anticoagulation System 63 APEX PD 63 Chemokine Therapeutics 63 Civacir 63 lead molecular radiotherapeutic 63 orBec R oral beclomethasone 63 glucokinase activator 63 VEGFR2 inhibitor 63 Cetrorelix 63 DepoCyt ® Abelcet ® 63 generation URAT1 inhibitor 63 acetonide FA 63 drug pipeline TAFA# 63 NasdaqGM SPPI 63 Aradigm Logo 63 IND Filing 63 orBec ® oral beclomethasone 63 ongoing Phase IIIb 63 Pafuramidine 63 OAB overactive bladder 63 Harbor BioSciences 63 Veronate R 63 confirmatory pivotal 63 Evoltra ® 63 visit www.targanta.com 63 MEK inhibitor RDEA# 63 Medidur TM FA 63 CERVARIX R 63 investigational monoclonal antibody 63 granted Ortec 63 BLA filing 63 SIX RO ROG 63 AERx iDMS 63 NASDAQ MNKD focuses 63 candidate MyVax 63 recombinant subunit vaccine 63 Sunesis Pharmaceuticals 63 Panzem R NCD 63 Nicotine Conjugate Vaccine 63 Urocidin TM 63 Initiates Phase 63 candidate CRLX# 63 Surfaxin LS 63 Chemophase 63 Immunotherapeutic 63 rALLy clinical trial 63 progressive metastatic prostate 63 overactive bladder AA# 63 BENLYSTA TM 63 Excellarate TM 63 XL# XL# 63 THR beta agonist 63 PROVENGE ® 63 Phase 2b Trial 63 ZK EPO 63 KNS # 63 EVIZON TM 63 triggers apoptosis programmed 63 Pruvel ™ 63 Ocrelizumab 63 albiglutide 63 IV APAP 63 Nasdaq HALO 63 bardoxolone 63 ELADUR ™ 63 Pralatrexate 63 Employment Inducement Awards 63 L BLP# 63 Files IND 63 Cloretazine ® 63 PRT# 63 TransVax TM 63 serious systemic Staphylococcal 63 2 methoxyestradiol 63 Nuvelo Announces 63 Oral NKTR 63 MAGE A3 ASCI 63 methylnaltrexone bromide 63 DNA methyltransferase inhibitors 63 personalized cellular immunotherapy 63 tubulin inhibitor 63 GATTEX ™ 63 Submits NDA 63 Hedgehog antagonist 63 OTCBB URGP specialty 63 http:/www.pharmacopeia.com 63 DARA logo 63 MSCRAMM ® 63 docetaxel Taxotere R 63 Locteron ® 63 Onalta 63 Phenoptin 63 Pimavanserin 63 Allovectin 7 63 candidate XP# 63 Phase IIb trials 63 Bicifadine 63 Ceflatonin R 63 dextromethorphan quinidine 63 GVAX ® 63 zolpidem tartrate sublingual tablet 63 SAR# [004] 63 include GALNS N 63 HCD# [002] 63 Asentar 63 Protexia ® 63 investigational pan BCR 63 Pruvel TM 63 Dacetuzumab 62 recombinant biopharmaceutical 62 malignant mesothelioma Alfacell 62 Sulonex TM 62 sorafenib tablets 62 SUTENT ® 62 sapropterin dihydrochloride Phase 62 orally administered inhibitor 62 TRIOLEX HE# APOPTONE HE# 62 Seliciclib 62 Talabostat 62 otelixizumab 62 PSN# [002] 62 AKIP ™ 62 www.vioquestpharm.com 62 Fibrillex TM 62 Regeneron Pharma 62 topical non steroidal 62 LHRH antagonist 62 OTC BB PVCT 62 TRANSDUR ™ 62 mesylate tablets approved 62 mecarbil 62 TRAIL receptor antibody 62 Aurora Kinase 62 Staphylococcus aureus Immune Globulin 62 TOCOSOL Paclitaxel 62 Aflibercept 62 Genz # 62 PI3K/Akt pathway inhibitor 62 Protexia R 62 CORT # 62 Dacogen injection 62 Nasdaq XTLB 62 IMPACS R 62 EmbraceAC 62 XP# XP# 62 forodesine hydrochloride 62 Trubion proprietary 62 Receives Approvable Letter 62 R lenalidomide 62 INSPIRE Trial Phase III 62 www.telik.com 62 rNAPc2 62 oral nucleoside analogue 62 MAXY alpha 62 faropenem medoxomil 62 CR# vcMMAE 62 serine protease inhibitor CU# 62 Pharmos proprietary 62 BioNumerik 62 immunosuppressive compound 62 NovaBay Aganocide 62 Ceragenin ™ 62 novel VDA molecule 62 Therapeutic Competitors Companies 62 please visit http:/www.vandapharma.com 62 YONDELIS 62 trastuzumab Herceptin R 62 AcryMed Incorporated 62 ENZON 62 Safinamide 62 compound ISA# 62 UCB www.ucb group.com 62 Biomerix Corporation 62 BLP# Liposome Vaccine 62 website http:/www.depomed.com 62 ProLindac TM 62 tiapamil 62 product candidate Lpathomab 62 novel L DOS# 62 including eniluracil ADH 62 Mipomersen 62 Annamycin 62 GSK '# 62 Vicriviroc 62 Elagolix 62 PrevOnco 62 LymphoStat B belimumab 62 thrombin component 62 BiovaxID TM 62 Phase IIa clinical trials 62 www.cellgenesys.com 62 www.vivus.com 62 commercializing oxidized glutathione 62 MT#/MEDI-# 62 Amigal 62 Allovectin 7 R 62 OTCBB PYTO 62 Hedgehog Pathway Inhibitor 62 Nasdaq VNDA 62 Augment TM 62 By JAMAAL ABDUL 62 Zemiva ™ 62 candidates Azedra TM 62 HCV polymerase 62 www.syntapharma.com 62 cladribine Cladribine Tablets 62 confirmatory Phase III 62 Telik Announces 62 Phase IIb Clinical Trial 62 TKB# 62 Immunex Corporation 62 Trofex TM 62 Reports Preclinical Data 62 label Lipofen R 62 neuropathic pain metabolic diseases 62 TLK# 62 ZYBRESTAT fosbretabulin 62 pseudobulbar affect PBA 62 Altus Pharmaceuticals 62 candidates Azedra 62 NYSE Amex PTN 62 Georges Gemayel 62 MGCD# MGCD# [001] 62 GED aPC 62 MKC# 62 bevirimat Study 62 Inc. Nasdaq VVUS 62 LymphoStat B TM 62 ALN HPN 62 Exherin TM 62 Syncria albiglutide 62 Submits Supplemental 62 novel synthetic PEGylated 62 MCSP respectively 62 oral ridaforolimus 62 Hsp# Inhibitor 62 AIMM trial 62 mitogen activated ERK kinase 62 sNDA submission 62 candidate TNFerade biologic 62 developing Zerenex ferric 62 memantine HCl 62 Relypsa 62 non peptidic protease 62 KRYSTEXXA TM 62 RANK Ligand inhibitor 62 Sphingomab 62 oral ghrelin agonist 62 Varespladib 62 Risperidone Oral Solution 62 nalbuphine ER 62 forodesine 62 Phase IIb clinical trials 62 ISTODAX 62 Aganocide TM 62 XOMA 3AB 62 Nuvion 62 P#X# antagonist 62 Sulonex 62 teplizumab 62 Auxilium transmucosal film 62 LEVADEX TM 62 signal detection CTSD 62 Omacetaxine 62 developing ACAPODENE 62 midstage trials 62 visit http:/www.mannkindcorp.com 62 Presents Preclinical 62 UPLYSO 62 GTC recombinant human 62 Pharma Merck Serono 62 include Phenoptin TM 62 Hybridon 62 Phase III LibiGel 62 Tramiprosate ALZHEMED TM 62 budesonide MMX Phase III 62 candidate HuCNS SC 62 Aztreonam lysine 62 ATPace TM 62 therapeutic monoclonal antibody 62 IRX 2 62 MT# MEDI 62 Liprotamase 62 intravesical infusion therapy 62 Topline Results 62 Sapacitabine 62 CDK cyclin dependent 62 STEDESA 62 Awarded Qualifying Therapeutic 62 please visit www.dyax.com 62 Onco TCS 62 using VIAdel TM 62 Genasense R oblimersen 62 6R BH4 62 epothilones 62 Phase 1b Clinical Trial 62 pafuramidine maleate 62 FermaVir 62 Telavancin 62 HCV protease inhibitor 62 incyclinide 62 proprietary intranasal insulin 62 MEK Inhibitor 62 3 registrational trial 62 Randomized Phase 62 XL# XL# XL# 62 compound KOS 62 Azedra 62 tramiprosate ALZHEMED TM 62 number NCT# ClinicalTrials.gov 61 Copegus R 61 StaphVAX R 61 Prostate AdenoCarcinoma Treatment 61 Aeolus Pharmaceuticals Announces 61 PSMA ADC 61 proteasome inhibitor 61 Inc. Nasdaq OXGN 61 Vitamin D analogue 61 nasal calcitonin product 61 ALN TTR 61 Thelin TM 61 candidate SILENOR TM 61 ASX PGL 61 EMPOWER ™ 61 solanezumab 61 Sopherion 61 anticancer compound 61 alvimopan 61 BioSante Pharmaceuticals Announces 61 www.adeonapharma.com 61 www.oxigene.com 61 small molecule Hedgehog 61 markets COLAZAL 61 Panzem 61 romazarit 61 Nasdaq DVAX 61 urocortin 2 61 secretory phospholipase A2 61 LymphoStat B 61 cosmetic cosmeceutical products 61 HDAC Inhibitor 61 Lucanix R 61 mGluR5 negative 61 Kuvan R 61 GTC recombinant form 61 Guanilib 61 Ganite ® 61 Valortim TM 61 Phase Ib IIa 61 FACTIVE R gemifloxacin 61 oral picoplatin 61 Cariprazine 61 RenaZorb TM 61 BHT DNA 61 Generx TM 61 Febuxostat 61 markets Testim ® 61 Randomized Phase II 61 R sorafenib tablets 61 Romidepsin 61 mertansine 61 Nasdaq CYCC Nasdaq CYCCP 61 Sphingomab TM 61 Troxatyl 61 dependent kinase inhibitor 61 ThermoDox R 61 seliciclib CYC# 61 brivanib 61 AEG# 61 FUSILEV ® 61 EDEMA3 61 Tech DVAX 61 Namenda Memantine HCl 61 anti CD3 monoclonal 61 dasatinib Sprycel ® 61 HCV NS5B polymerase 61 Cintredekin Besudotox 61 evaluating intravenous picoplatin 61 Bayer HealthCare Onyx Pharmaceuticals 61 Novel Antibiotic 61 tivozanib AV 61 Aryplase 61 velafermin belinostat 61 Trofex 61 apoptosis inducer 61 read Palintologist 61 myelofibrosis polycythemia vera 61 Selective Electrochemical Tumor Ablation 61 evaluating mipomersen 61 pralatrexate 61 Bezielle 61 Tolerx 61 DIFICID ™ 61 OLGX 61 proprietary Capillary Aerosolization Technology 61 Mylan Receives Approval 61 NASDAQ LGND 61 refractory chronic lymphocytic 61 novel trazodone formulation 61 telaprevir VX 61 development peramivir neuraminidase 61 Anturol 61 CK # novel 61 Zerenex ™ 61 TAFA# 61 5 lipoxygenase activating 61 torsemide ER 61 histamine dihydrochloride 61 cathepsin K inhibitor 61 Small Molecule 61 BEMA ® 61 Nasdaq SGEN 61 eniluracil 61 ELADUR TM 61 octreotide implant 61 hepatitis C polymerase inhibitor 61 Ozarelix 61 TOCOSOL Camptothecin 61 CYT# potent vascular disrupting 61 SYMMETRY SM trial 61 ganetespib 61 BXT # 61 include VALSTAR TM 61 John F. Thero 61 Receptos 61 Announces Tentative Approval 61 Teplizumab 61 supplemental biologics 61 Dyax logo 61 Nasdaq AVNR 61 Onconase 61 systemic anaplastic large 61 EOquin TM phase 61 Nasdaq EPCT 61 dacetuzumab 61 ® decitabine 61 KIACTA ™ 61 Randomized Double blind 61 PEGylated docetaxel 61 Elesclomol 61 Belinostat 61 Combination REOLYSIN R 61 liposomal formulation 61 BEMA Granisetron 61 evaluating T DM1 61 Myocet 61 Collaborators Present 61 Aurora kinase inhibitor 61 ARISE Phase III 61 ocrelizumab 61 Alfacell proprietary ribonuclease 61 FOLFOX6 chemotherapy regimen 61 Q#IR 61 specific lectin receptors 61 Alseres Cethrin 61 kidney urologic 61 Solazed 61 delivery polymer matrix 61 oral gallium 61 fostamatinib 61 ZOLINZA 61 selective androgen receptor modulator 61 Metastatic Melanoma 61 RGB # 61 ospemifene 61 IND Investigational New 61 CTA# Injection 61 oxybutynin ATD TM 61 AKT inhibitor 61 commercialize OncoGenex lead 61 Phase lll 61 adecatumumab MT# 61 Voreloxin 61 BRIM3 61 Initiates Phase 2b 61 PDE# inhibitors 61 Specifid 61 GLPG# 61 Merck OSI Pharmaceuticals 61 candidate Zenvia 61 VIVITROL ® 61 Lung Cancer Drug 61 Diabetic Macular Edema 61 pivotal bioequivalence 61 NPC 1C 61 Sudhir Agrawal D.Phil 61 proprietary intravenous formulation 61 CYP#A# CYP#D# 61 nonclinical studies 61 Pirfenidone 61 advanced compound INCB# 61 NS5b 61 modified glutathione analog 61 eprodisate Fibrillex TM 61 TM Aganocide 61 Daclizumab 61 Phase III Clinical Trial 61 CCX# 61 Sangamo BioSciences Announces 61 Exelixis logo 61 telomerase inhibitor drug 61 palifosfamide Zymafos TM 61 Wellstat 61 Initiate Phase III 61 cancer indications bafetinib 61 Milestone Payment From 61 Perflubutane Polymer Microspheres 61 CYT# vascular disrupting 61 MEND CABG II 61 Arqule 61 Chimigen TM 61 Xanafide 61 diagnostic radiopharmaceutical 61 Genentech Wyeth Pharmaceuticals 61 hormone LHRH antagonist 61 SYCREST 61 Intermezzo ® zolpidem tartrate 61 fosbretabulin 61 Curaxin 61 pipeline GlycoPEG GCSF 61 Cardioxyl Pharmaceuticals 61 Idun Pharmaceuticals 61 OTC BB PVCT http:/www.pvct.com 61 Ecallantide 61 novel orally inhaled 61 SPRYCEL ® 61 6 sulfatase 61 Stimuvax R 61 Sciences ABthrax Albuferon 61 Pharmos pipeline 61 please visit http:/www.supergen.com 61 pharmacokinetic PK study 61 CEFF financings subject 60 limiting toxicity DLT 60 MGd 60 Omigard 60 CCR9 antagonist 60 website www.depomedinc.com 60 Nanobody R 60 Fodosine 60 Dr. Cauwenbergh 60 Dr. Scangos 60 phase IIa clinical 60 novel emulsion formulation 60 EHT AGN 60 selective A2A adenosine receptor 60 ridaforolimus 60 Canvaxin 60 Fast Track Status 60 Biologic License Application BLA 60 mGluR5 NAM 60 CG# oncolytic virus 60 diabetes irritable bowel 60 PEG Interferon lambda 60 ruxolitinib 60 Azedra TM 60 Bifunctional Muscarinic Antagonist Beta2 60 faropenem 60 Investigational Oral 60 Nereus Pharmaceuticals 60 Systemic Delivery 60 Solazed TM 60 BioGeneriX 60 IMC A# 60 Trubion Pharmaceuticals TRBN 60 LE SN# 60 Solzira TM 60 MEK inhibitor 60 Cetrorelix pamoate 60 Pharmion Corporation 60 Neuradiab 60 LibiGel ® 60 Syntonix 60 Tarceva TM 60 Alnylam #x# 60 NP2 Enkephalin 60 Entereg TM 60 Medarex logo 60 next generation URAT1 60 ocular formulation 60 cardiac myosin activator omecamtiv 60 intranasal insulin product 60 Deforolimus 60 NASDAQ CLSN 60 PROSTASCINT R 60 5 HT2A inverse 60 MAXY VII 60 2A receptor agonist 60 SinuNase 60 gastro intestinal inflammation 60 HCV protease 60 First Patient Dosed 60 systemic Phase 1b 60 IMiDs ® compound 60 sodium glucose transporter 60 Nasdaq AEGR 60 Orapred ODT 60 CRD5 60 Nabi HB Intravenous 60 ATL# [002] 60 Phase Ib II 60 EXPLORE Xa 60 registrational 60 Zybrestat 60 active AKT inhibitor 60 Advancing Drugs 60 visit biotech.com 60 Nasdaq HALO biopharmaceutical 60 Completes Enrollment 60 Aurora kinase 60 registrational trial 60 candidate epratuzumab 60 SNT MC# 60 Cloretazine 60 Xcellerated T Cells 60 vapreotide acetate 60 AQD class 60 factor VIIa 60 ARIKACE ™ 60 bile duct tumor 60 skeletal sarcomere activators 60 5 HT6 receptor 60 investigational antiplatelet agent 60 Ceplene TM 60 http:/www.vical.com 60 CoTherix logo 60 product TNFerade TM 60 OMP #R# 60 Patient Enrollment 60 EGS# 60 PEG PAL 60 Agonist MABA program 60 CRACM 60 investigational pharmacologically unique 60 Civacir TM Hepatitis C 60 Soliris TM eculizumab 60 initiated Phase Ib 60 Antibody Drug Conjugate 60 lead Aganocide compound 60 R#/MEM 60 Zerenex 60 PORxin TM platforms 60 initiate multicenter 60 Corlux 60 lucinactant 60 website http:/www.celsion.com 60 gastrin analogue TT 60 Tibotec BVBA 60 Craig Tooman 60 DOS# 60 topically applied SEPA 60 Phase III ADT 60 MOVIPREP R 60 Restanza 60 fipamezole 60 AZD# TC 60 severe hypercholesterolemia 60 AN# novel 60 Syncria 60 pan histone deacetylase 60 HGS# 60 phase IIb trial 60 plasma kallikrein inhibitor 60 Prodarsan ® 60 Genasense oblimersen sodium Injection 60 Nasdaq MNKD focuses 60 adenosine injection 60 Perifosine 60 targeted anticancer biopharmaceuticals 60 TransVax tm 60 novel anti infective 60 GRNVAC1 60 http:/www.sunesis.com 60 ularitide 60 Diamyd Medical Diamyd 60 Peginterferon alfa 2b 60 dihydrochloride Tablets 60 Nexavar ® 60 Investigational Treatment 60 www.micromet inc.com 60 novel immunotherapies 60 inflammatory PDE 60 Telatinib 60 oral calcitonin licensed 60 SAR# [002] 60 RTP #i 60 Factor VIIa 60 HDL Selective Delipidation 60 Phase 2a Trial 60 antibody MAb 60 Friedreich Ataxia FRDA 60 Proellex TM 60 Qutenza TM 60 KOSN 60 product Fentanyl TAIFUN 60 Homspera TM 60 www.BMRN.com 60 RELOVAIR ™ 60 CCR5 mAb 60 ZEGERID Capsules 60 Inc. NASDAQ NOVC 60 NASDAQ DYAX 60 ragweed allergy immunotherapeutic 60 Neo Kidney Augment